VESICOLOBULLOUS LESIONS(IMMUNOLOGIC DISEASES - PEMPHIGUS VULGARIS) Flashcards
1
Q
CONCEPT
A
GROUP OF AUTOIMMUNE MUCOCUTANEOUS DISEASES
2
Q
CHARACTERISTICS
A
INTRAEPITHELIAL BLISTER FORMATION (RESULTS FROM A BREAKDOWN OR LOSS OF INTERCELLULAR ADHESION PRODUCING EPITHELIAL CELL SEPARATION (ACANTHOLYSIS)
3
Q
MECHANISM
A
- WIDESPREAD SUPERFICIAL ULCERATION FOLLOWING RUPTURE OF THE BLISTERS LEADS TO PAINFUL DEBILITATION, FLUID LOSS, ELECTROLYTE IMBALANCE
- BLISTERING: DUE ABNORMAL PRODUCTION OF AUTOANTIBODIES (DIRECTED AGAINST THE EPIDERMAL CELL SURFACE GLYCOPROTEINS, DESMOGLEIN 3 AND DESMOGLEIN 1(COMPONENTS OF DESMOSSOMOS)
- RESULT OF IMMUNOLOGIC ATTACK ON THE DESMOSOMES: SPLIT DEVELOPS WITHIN THE EPITHELIUM, CAUSING A BLISTER TO FORM WHICH IS LARGE SUPERFICIAL FRAGILE THAT BURST EASILY
4
Q
TYPES
A
1) PEMPHIGUS VULGARIS (MOST COMMON)
2) PEMPHIGUS VEGENTANS
3) PEMPHIGUS FOLIACEUS
4) PEMPHIGUS ERYTHEMATOSUS
5
Q
UNTREATED
A
PATIENT’S DEATH
6
Q
ORAL LESIONS
A
- FIRST SIGN OF THE DISEASE (DIFFICULT RESOLVE WITH THERAPY)
- LARGE AREAS ULCERATION: ANY ORAL MUCOSA (PALATE, LABIAL MUCOSA, BUCCAL MUCOSA, VENTRAL TONGUE, GINGIVA
- INTACT BULLAE: RARELY SEEN IN ORAL CAVITY
7
Q
TARGET PUBLIC
A
ADULTS (50 YEARS AVERAGE)
8
Q
HYSTOPATHOLOGIC FEATURES
A
- VESICLES/BULLAE FORMED ENTIRELY INTRA-EPITHELIALLY, JUST ABOVE THE BASAL LAYER OF CELLS (SUPRABASILAR VESICLES)
- SOMETIMES ENTIRE SUPERFICIAL LAYERS OF THE EPITHELIUM ARE STRIPPED AWAY, LEAVING ONLY THE BASAL CELLS, WHICH HAVE BEEN DESCRIBED AS “ROW OF TOMBSTONES”
- CELLS OF THE SPINOUS LAYER OF THE SURFACE EPITHELIUM TYPICALLY APPEAR TO FALL APART (ACANTHOLYSIS), AND LOOSE CELLS TEND TO ASSUME A ROUNDED SHAPE (TZANCK CELLS)
9
Q
DIAGNOSIS
A
- STANDARD BIOPSY/IMMUNOFLUORESCENCE (DIF) TESTING (DEMONSTRATE AUTOANTIBODY ALREADY ATTACHED TO THE TISSUE)
- WITH THIS PROCEDURE: ANTIBODIES (IgG/IgM) AND COMPLEMENT COMPONENTS (C3) CAN BE DEMONSTRATED IN THE INTERCELLULAR SPACES BETWEEN THE EPITHELIAL CELLS
- CHICKEN WIRE PATTERN
10
Q
TREATMENT
A
SYSTEMIC CORTICOSTEROIDS (PREDNISONE)/COMBINATION WITH OTHER IMMUNOSUPPRESSIVE DRUGS